PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-21.27%
G&A reduction while Healthcare median is 0.00%. Seth Klarman would investigate efficiency gains.
No Data
No Data available this quarter, please select a different quarter.
264.51%
Other expenses change of 264.51% versus flat Healthcare costs. Walter Schloss would verify efficiency.
3.15%
Operating expenses change of 3.15% versus flat Healthcare costs. Walter Schloss would verify control.
3.15%
Total costs change of 3.15% versus flat Healthcare costs. Walter Schloss would verify control.
-0.34%
Interest expense reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
-75.00%
D&A reduction while Healthcare median is 0.00%. Seth Klarman would investigate efficiency.
15.50%
EBITDA change of 15.50% versus flat Healthcare. Walter Schloss would verify quality.
No Data
No Data available this quarter, please select a different quarter.
16.24%
Income change of 16.24% versus flat Healthcare. Walter Schloss would verify quality.
No Data
No Data available this quarter, please select a different quarter.
-3.90%
Other expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
3.90%
Tax expense change of 3.90% versus flat Healthcare. Walter Schloss would verify strategy.
12.65%
Income change of 12.65% versus flat Healthcare. Walter Schloss would verify quality.
No Data
No Data available this quarter, please select a different quarter.
12.55%
EPS change of 12.55% versus flat Healthcare. Walter Schloss would verify quality.
12.55%
Diluted EPS change of 12.55% versus flat Healthcare. Walter Schloss would verify quality.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.